United States - English - NLM (National Library of Medicine)

hospira, inc. - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - cefepime for injection is indicated in the treatment of pneumonia (moderate to severe) caused by susceptible strains of streptococcus pneumoniae , including cases associated with concurrent bacteremia, pseudomonas aeruginosa , klebsiella pneumoniae , or enterobacter species. cefepime for injection as monotherapy is indicated for empiric treatment of febrile neutropenic patients. in patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy, or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate. insufficient data exist to support the efficacy of cefepime monotherapy in such patients [see clinical studies (14.1)] . cefepime for injection is indicated in the treatment of uncomplicated and complicated urinary tract infections (including pyelonephritis) caused by susceptible isolates of escherichia coli or klebsiella pneumoniae , when the infec

United States - English - NLM (National Library of Medicine)

wg critical care, llc - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - cefepime for injection is indicated in the treatment of pneumonia (moderate to severe) caused by susceptible strains of streptococcus pneumoniae , including cases associated with concurrent bacteremia, pseudomonas aeruginosa , klebsiella pneumoniae , or enterobacter species. cefepime for injection as monotherapy is indicated for empiric treatment of febrile neutropenic patients. in patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy, or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate. insufficient data exist to support the efficacy of cefepime monotherapy in such patients [see clinical studies (14.1)] . cefepime for injection is indicated in the treatment of uncomplicated and complicated urinary tract infections (including pyelonephritis) caused by susceptible isolates of escherichia coli or klebsiella pneumoniae , when the infec

United States - English - NLM (National Library of Medicine)

xellia pharmaceuticals usa llc - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - cefepime for injection is indicated in the treatment of pneumonia (moderate to severe) caused by susceptible strains of streptococcus pneumoniae , including cases associated with concurrent bacteremia, pseudomonas aeruginosa , klebsiella pneumoniae , or enterobacter species. cefepime for injection as monotherapy is indicated for empiric treatment of febrile neutropenic patients. in patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy, or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate. insufficient data exist to support the efficacy of cefepime monotherapy in such patients [see clinical studies (14.1)] . cefepime for injection is indicated in the treatment of uncomplicated and complicated urinary tract infections (including pyelonephritis) caused by susceptible isolates of escherichia coli or klebsiella pneumoniae , when the infec

Australia - English - Department of Health (Therapeutic Goods Administration)

cefepime hydrochloride monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - cefepime -

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

open joint stock company "borisovskiy zavod medicinskikh preparatov" - cefepime (cefepime hydrochloride) - powder for solution for injection - 1000mg

United States - English - NLM (National Library of Medicine)

piramal critical care inc. - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - 1.1 pneumonia cefepime for injection is indicated in the treatment of pneumonia (moderate to severe) caused by susceptible strains of streptococcus pneumoniae, including cases associated with concurrent bacteremia, pseudomonas aeruginosa, klebsiella pneumoniae, or enterobacter species. 1.2 empiric therapy for febrile neutropenic patients cefepime for injection as monotherapy is indicated for empiric treatment of febrile neutropenic patients. in patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy, or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate. insufficient data exist to support the efficacy of cefepime monotherapy in such patients [see clinical studie s ( 14.1)]. 1.3 uncomplicated and complicated urinary tract infections (including pyelonephritis) cefepime for injection is indicated in the treatment of uncomplicated and co

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ldp laboratorios torlan s.a. - cefepime dihydrochloride monohydrate 1189,14 mg - eq. cefepime 1000 mg - powder for solution for injection/infusion - 1000 mg - cefepime dihydrochloride monohydrate 1189.14 mg - cefepime

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ldp laboratorios torlan s.a. - cefepime dihydrochloride monohydrate 2378,28 mg - eq. cefepime 2000 mg - powder for solution for injection/infusion - 2000 mg - cefepime dihydrochloride monohydrate 2378.28 mg - cefepime

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - cefepime dihydrochloride monohydrate 1,213 g - eq. cefepime 1000 mg - powder for solution for injection/infusion - 1 g - cefepime dihydrochloride monohydrate 1213 mg - cefepime